Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes - Van Hees, S; Bourgeois, S; Van Vlierberghe, H; Belgian NA Stop Study Group (Aliment Pharmacol Ther, 2018)